Pancreatic Cancer Research

ResearcherLMU KlinikumActive in the last 2 years

Simon Sirtl

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6047-334X; OpenAlex author ID A5091385292. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 2 papers

Papers 8

  1. Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multic… Co-author DOI 10.1016/s2468-1253(25)00056-1↗
  2. Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report. Co-author DOI 10.1159/000545975↗
  3. [Pancreatic cancer-screening or surveillance?] Co-author DOI 10.1007/s00117-023-01227-3↗
  4. In-vitro model to mimic T cell subset change in human PDAC organoid co-culture. Co-author DOI 10.1007/s00432-023-05100-7↗
  5. Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancr… Co-author DOI 10.1053/j.gastro.2022.07.047↗
  6. TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status. Co-author DOI 10.3390/cancers14215240↗
  7. Incidental Finding of a PSMA-Positive Pancreatic Cancer in a Patient Suffering from a Metastasized PSMA-Positive Prostate Cancer. Co-author DOI 10.3390/diagnostics11010129↗
  8. [Diabetes and pancreatic cancer - state of the art]. Co-author DOI 10.1007/s15006-020-0428-5↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Julia V. Mayerle · 6 shared papers, 2020–2025 · strength 1.00
  2. Marlies Vornhülz · 3 shared papers, 2022–2025 · strength 0.55
  3. Georg Beyer · 3 shared papers, 2022–2025 · strength 0.55
  4. Kathrin Heinrich · 2 shared papers, 2023–2025 · strength 0.36
  5. Christoph Benedikt Westphalen · 2 shared papers, 2023–2025 · strength 0.36
  6. Elisabetta Goni · 2 shared papers, 2020–2022 · strength 0.27
  7. Ivonne Regel · 2 shared papers, 2022–2023 · strength 0.25
  8. Ujjwal Mukund Mahajan · 2 shared papers, 2022 · strength 0.24
  9. Paul Rogowski · 1 shared paper, 2025 · strength 0.21
  10. Volker Heinemann · 1 shared paper, 2025 · strength 0.21
  11. Alexander Kleger · 1 shared paper, 2025 · strength 0.21
  12. Alexandr V. Bazhin · 1 shared paper, 2023 · strength 0.15
  13. Bernhard Willibald Renz · 1 shared paper, 2023 · strength 0.15
  14. Matthias Ilmer · 1 shared paper, 2023 · strength 0.15
  15. Hanno Nieß · 1 shared paper, 2023 · strength 0.15
  16. Maximilian Reichert · 1 shared paper, 2023 · strength 0.15
  17. Iris Beirith · 1 shared paper, 2023 · strength 0.15
  18. M. Knoblauch · 1 shared paper, 2023 · strength 0.15
  19. Jens Werner · 1 shared paper, 2023 · strength 0.15
  20. Ignazio Piseddu · 1 shared paper, 2022 · strength 0.13
  21. Enrico Narciso De Toni · 1 shared paper, 2022 · strength 0.13
  22. Najib Ben Khaled · 1 shared paper, 2022 · strength 0.13
  23. Waldemar H. Uhl · 1 shared paper, 2022 · strength 0.11
  24. Fritz Klein · 1 shared paper, 2022 · strength 0.11
  25. Frank Ulrich Weiß · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.